Michael Lattanzi

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Topics

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Expert review of anticancer therapy

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Brendan J Guercio, Michal Sarfaty, Min Yuen Teo, Neha Ratna, Cihan Duzgol, Samuel A Funt, Chung-Han Lee, David Henry Aggen, Ashley M Regazzi, Zhiyu Chen, Michael Lattanzi, Hikmat A Al-Ahmadie, Angela Rose Brannon, Ronak H Shah, Carissa E Chu, Andrew T Lenis, Eugene J Pietzak, Bernard H Bochner, Michael F Berger, David B Solit, Jonathan E Rosenberg, Dean F Bajorin, Gopakumar V Iyer
Clinical and genomic landscape of FGFR3-altered urothelial carcinoma and treatment outcomes with erdafitinib: a real-world experience. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Samuel A Funt, Michael Lattanzi, Karissa A Whiting, Hikmat A Al-Ahmadie, Colleen Quinlan, Min Yuen Teo, Chung-Han Lee, David Henry Aggen, Danielle Zimmerman, Deaglan Joseph McHugh, Arlyn Apollo, Trey D Durdin, Hong Truong, Jeffrey Kamradt, Maged Khalil, Bradley Lash, Irina Ostrovnaya, Asia S McCoy, Grace Hettich, Ashley M Regazzi, Marwah Jihad, Neha Ratna, Abigail Boswell, Kaitlyn Francese, Yuanquan Yang, Edmund Folefac, Harry W Herr, S Machele Donat, Eugene J Pietzak, Eugene K Cha, Timothy F Donahue, Alvin C Goh, William C Huang, Dean F Bajorin, Gopakumar V Iyer, Bernard H Bochner, Arjun V Balar, Amir Mortazavi, Jonathan E Rosenberg
Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (12) (2022)
Michael Lattanzi, Samuel A Funt, Jonathan E Rosenberg
Reply to S. Zhang. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (23) (2022)
Michael Lattanzi, Jonathan E Rosenberg
The emerging role of antibody-drug conjugates in urothelial carcinoma. Expert review of anticancer therapy 20 (7) (2020)
Anna Pavlick, Ana B Blazquez, Marcia Meseck, Michael Lattanzi, Patrick A Ott, Thomas U Marron, Rose Marie Holman, John Mandeli, Andres M Salazar, Christopher B McClain, Gustavo Gimenez, Sreekumar Balan, Sacha Gnjatic, Rachel Lubong Sabado, Nina Bhardwaj
Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma. Cancer immunology research 8 (1) (2019)
Michael Lattanzi, Joseph Han, Una Moran, Kierstin Utter, Jeremy Tchack, Rachel Lubong Sabado, Russell Berman, Richard Shapiro, Hsin-Hui Huang, Iman Osman, Nina Bhardwaj, Anna C Pavlick
Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis. Journal for immunotherapy of cancer 6 (1) (2018)